Press Archive

The AIDS and Cancer Specimen Resource has been renewed for five years with GW serving as the primary site.

GW Cancer Center researchers found that PTEN, a tumor suppressor gene mutated in approximately 20% of primary prostate cancers, and in as many as 50% of androgen deprivation-resistant prostate cancers, relies on another gene, ARID4B, to function. 

A new development series aimed at furthering health equity education for educators and health care providers was launched earlier this month by the George Washington University (GW) School of Medicine and Health Sciences (SMHS) Department of Clinical Research and Leadership.

Dominic Raj, MD, director of the Division of Renal Disease and Hypertension at SMHS, received the award from the American Association of Kidney Patients.

Raja Mazumder, PhD, professor of biochemistry and molecular medicine, authored a paper published in PLOS ONE outlining the baseline biome of a healthy human gut. This will serve as a reference for doctors, patients, and researchers, giving them an idea of what a “normal” human microbiome…

Homa Ahmadzia, MD, has received a K23 grant for her research investigating postpartum hemorrhage and ways of minimizing it.

Antonia R. Sepulveda, MD, PhD, has been selected to serve as chair of the Department of Pathology at the GW School of Medicine and Health Sciences. She will also serve as the Ralph E. Lowey Professor of Oncology, as well as chief of pathology service and clinical laboratory director at GW…

Barbara Lee Bass, a widely respected academic medicine leader, surgeon and researcher who completed her residency and served on faculty at the GW, has been named vice president for health affairs and dean of the SMHS.

The editorial team of JAAPA, including Reamer L. Bushardt, PharmD, PA-C, DFAAPA, senior associate dean for health sciences, Harrison Reed, MMSc, PA-C, assistant professor of physician assistant studies, and Teri L. Capshaw, MBA, communications and editorial director for health sciences, was…

A team at the GW Cancer Center has identified the protein ERK as an important mechanism behind platinum-resistance in platinum-resistant ovarian cancer.